SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-001309
Filing Date
2024-08-01
Accepted
2024-07-31 18:29:55
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20240630.htm   iXBRL 10-Q 1370399
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 19874
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 7197
  Complete submission text file 0001753926-24-001309.txt   7653288

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20240630_def.xml EX-101.DEF 288348
3 PRESENTATION tlcc-20240630_pre.xml EX-101.PRE 451510
4 CALCULATION tlcc-20240630_cal.xml EX-101.CAL 95936
5 LABEL tlcc-20240630_lab.xml EX-101.LAB 771459
6 SCHEMA tlcc-20240630.xsd EX-101.SCH 54935
68 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20240630_htm.xml XML 1257189
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 241163421
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)